Literature DB >> 31506749

Robot-assisted laparoscopic pyeloplasty in infants and children: is it superior to conventional laparoscopy?

Ciro Andolfi1,2, Brittany Adamic3, Jerry Oommen4, Mohan S Gundeti3.   

Abstract

INTRODUCTION: Open pyeloplasty (OP) has been the first-line treatment for ureteropelvic junction obstruction (UPJO) since it was first described by Anderson and Hynes. The use of minimally invasive surgery (MIS) to treat UPJO in the pediatric population has increased in recent years, due to decreased morbidity and shorter recovery times. Recently, robot-assisted laparoscopic pyeloplasty (RALP) has seen a steady expansion. Unlike laparoscopic pyeloplasty (LP), RALP comes with a more manageable learning curve aided by specialized technological advantages such as high-resolution three-dimensional view, tremor filtration with motion scaling, and highly dexterous wrist-like instruments. With this review, we aim to highlight the trend toward robotic pyeloplasty over laparoscopy and current available evidence on outcomes.
METHODS: We systematically searched the PubMed and EMBASE databases, and we critically reviewed the available literature on the use of laparoscopy and robotic technology in pediatric patients with UPJO.
RESULTS: Overall, we selected 19 original articles and 5 meta-analyses. The available literature showed that the robotic approach to the UPJO allowed for decreased operative times, shorter length of hospital stay, lower complication rates, with success rates comparable to LP. Conflicting results persist regarding robotic platform and equipment costs.
CONCLUSION: While laparoscopy requires advanced skills for complex reconstructive procedures, such as pyeloplasty, robot-assisted surgery offers the valuable potential of making MIS more accessible to these types of procedure. Robotic technology has contributed to shortening the learning curve by acting as a bridge between open and endoscopic approach. There is still a strong need for higher quality evidence in the form of prospective observational studies and clinical trials, as well as further cost-effectiveness analyses. As robotic surgical technology spreads, future systems will be developed, offering smaller and more flexible tools, allowing enhanced applications on pediatric patients.

Entities:  

Keywords:  Laparoscopic pyeloplasty; Pediatric urology; Robot-assisted laparoscopic pyeloplasty; Robotic pyeloplasty; Ureteropelvic junction obstruction

Mesh:

Year:  2019        PMID: 31506749     DOI: 10.1007/s00345-019-02943-z

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  5 in total

1.  [Trends in upper urinary tract reconstruction surgery over a decade based on a multi-center database].

Authors:  W Zuo; F Gao; C W Yuan; S W Xiong; Z H Li; L Zhang; K L Yang; X F Li; L Liu; L Wei; P Zhang; B Wang; Y M Gu; H J Zhu; Z Zhao; X S Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2022-08-18

2.  Attaining competency and proficiency in open pyeloplasty: a learning curve configuration using cumulative sum analysis.

Authors:  Jin K Kim; Michael E Chua; Mandy Rickard; Karen Milford; Daniel T Keefe; Armando J Lorenzo
Journal:  Int Urol Nephrol       Date:  2022-05-19       Impact factor: 2.266

3.  Transperitoneal Versus Retroperitoneal Robotic-assisted Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction in Children. A Multicentre, Prospective Study.

Authors:  Thomas Blanc; Olivier Abbo; Fabrizio Vatta; Julien Grosman; Fabienne Marquant; Caroline Elie; Mélodie Juricic; Samia Laraqui; Aline Broch; Alexis Arnaud
Journal:  Eur Urol Open Sci       Date:  2022-06-15

4.  A Comparative Analysis of Robot-Assisted Laparoscopic Pyeloplasty in Pediatric and Adult Patients: Does Age Matter?

Authors:  Bosik Kang; Jungyo Suh; Bumjin Lim; Kun Suk Kim; Sang Hoon Song
Journal:  J Clin Med       Date:  2022-09-25       Impact factor: 4.964

5.  Are there disparities in access to robot-assisted laparoscopic surgery among pediatric urology patients? US institutional experience.

Authors:  Amrita Mohanty; Alyssa M Lombardo; Clark Judge; Mohan S Gundeti
Journal:  Int J Urol       Date:  2022-03-26       Impact factor: 2.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.